Secukinumab
5 NDCs across 1 manufacturer|0 Generic,5 Brand
Secukinumab is used to treat psoriatic arthritis and ankylosing spondylitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $1.6 billion on Secukinumab across 178,000 claims for 28,000 beneficiaries.
Secukinumab is available as 5 NDCs from 1 manufacturer (0 generic, 5 brand), with NADAC prices from $3924.35 to $7879.81 per ML — the most expensive product costs about 2.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
0G / 5B
Manufacturers
1
competing in market
Price Spread
$3924.35 – $7879.81
per ML
7d Activity
avg +0.1% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Novartis Pharmaceuticals Corporation manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Interleukin-17A Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing SECUKINUMAB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
COSENTYX 150 MG/ML SYRINGE | $7879.8111 per ML | +0.13% |
COSENTYX SENSOREADY 150 MG/ML PEN | $7858.4754 per ML | +0.05% |
COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN) | $4087.4067 per ML | -0.02% |
COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) | $3946.3486 per ML | +0.12% |
COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES | $3924.3531 per ML | — |
Frequently Asked Questions
What is Secukinumab used to treat?
Secukinumab is used to treat psoriatic arthritis and ankylosing spondylitis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Secukinumab?
In 2024, Medicare Part D spent $1.6 billion on Secukinumab across 178,000 claims for 28,000 beneficiaries.
How many Secukinumab products are on the market?
The Secukinumab drug market contains 5 NDCs from 1 manufacturer — 0 generic and 5 brand products.
What is the price range for Secukinumab?
NADAC reference prices for Secukinumab range from $3924.3531 to $7879.8111 per ML — the most expensive product costs about 2.0× the cheapest.
Which manufacturers make Secukinumab?
1 manufacturer lists Secukinumab in NADAC. Ranked by number of NDCs, the largest are Novartis Pharmaceuticals Corporation (5).
How has the price of Secukinumab changed recently?
Over the past 7 days, 3 Secukinumab NDCs rose and 1 fell, with a market-wide average change of +0.1%.